Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Crispr Pioneers Win 2020 Nobel Prize for Chemistry



Farhud DD1, 2, 3 ; Zarifyeganeh M3, 4
Authors
Show Affiliations
Authors Affiliations
  1. 1. School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Basic Sciences/Ethics, Academy of Medical Sciences, Tehran, Iran
  3. 3. Farhud Genetic Clinic, Tehran, Iran
  4. 4. Cellular and Molecular Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Source: Iranian Journal of Public Health Published:2020

Abstract

Over the last few years, the development of genome editing has revolutionized research on the human genome. Recent advances in developing programmable nucleases, such as meganucleases, ZFNs, TALENs and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas, has greatly expedited the progress of gene editing from concept to clinical practice. The CRISPR has advantages over other nuclease-based genome editing tools due to its high accuracy, efficiency, and strong specificity. Eight years after CRISPR application for human genome edition by Emmanuelle Charpentier and Jennifer A. Doudna, the 2020 Nobel Prize in Chemistry has been jointly given to them for development of CRISPR-Cas9 gene editing, allows scientists to precisely cut and edit of DNA. © 2020, Iranian Journal of Public Health. All rights reserved.
Other Related Docs
9. Crispr-Cas9-Mediated Gene Therapy in Lung Cancer, Clinical and Translational Oncology (2023)
14. Advancing Mesenchymal Stem Cell Therapy With Crispr/Cas9 for Clinical Trial Studies, Advances in Experimental Medicine and Biology (2020)